Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 36% ± 20% | |
lung | 12 studies | 31% ± 11% | |
peripheral blood | 9 studies | 24% ± 8% | |
eye | 9 studies | 34% ± 16% | |
heart | 4 studies | 33% ± 7% | |
liver | 4 studies | 39% ± 15% | |
adipose | 4 studies | 39% ± 18% | |
bone marrow | 3 studies | 21% ± 6% | |
intestine | 3 studies | 24% ± 8% | |
kidney | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 12130.20 | 1445 / 1445 | 100% | 51.43 | 183 / 183 |
breast | 100% | 9752.38 | 459 / 459 | 100% | 47.20 | 1114 / 1118 |
lung | 100% | 8426.61 | 577 / 578 | 100% | 36.78 | 1152 / 1155 |
ovary | 100% | 9712.17 | 180 / 180 | 100% | 20.78 | 428 / 430 |
prostate | 100% | 7318.59 | 245 / 245 | 99% | 35.50 | 499 / 502 |
thymus | 100% | 11281.02 | 653 / 653 | 99% | 41.00 | 600 / 605 |
intestine | 100% | 8808.77 | 966 / 966 | 99% | 28.94 | 522 / 527 |
stomach | 100% | 8138.48 | 359 / 359 | 99% | 30.64 | 283 / 286 |
bladder | 100% | 9786.19 | 21 / 21 | 99% | 28.95 | 498 / 504 |
uterus | 100% | 9705.68 | 170 / 170 | 99% | 33.41 | 453 / 459 |
brain | 98% | 5931.12 | 2595 / 2642 | 100% | 32.00 | 703 / 705 |
kidney | 100% | 5825.01 | 89 / 89 | 98% | 30.25 | 881 / 901 |
pancreas | 99% | 4622.16 | 324 / 328 | 99% | 32.45 | 176 / 178 |
adrenal gland | 100% | 11060.17 | 258 / 258 | 97% | 24.79 | 224 / 230 |
skin | 100% | 11701.26 | 1809 / 1809 | 97% | 32.08 | 457 / 472 |
liver | 100% | 6299.75 | 226 / 226 | 96% | 21.88 | 390 / 406 |
adipose | 100% | 9993.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8549.34 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.12 | 29 / 29 |
muscle | 100% | 30608.79 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6845.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.64 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 71.06 | 79 / 80 |
heart | 95% | 6795.17 | 818 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 45% | 2445.04 | 420 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0048856 | Biological process | anatomical structure development |
GO_0035904 | Biological process | aorta development |
GO_0003170 | Biological process | heart valve development |
GO_0003281 | Biological process | ventricular septum development |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0016607 | Cellular component | nuclear speck |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | HECTD1 |
Protein name | E3 ubiquitin-protein ligase (EC 2.3.2.26) E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECT domain E3 ubiquitin protein ligase 1 |
Synonyms | hCG_1812148 KIAA1131 |
Description | FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates . Mediates 'Lys-63'-linked polyubiquitination of HSP90AA1 which leads to its intracellular localization and reduced secretion (By similarity). Negatively regulating HSP90AA1 secretion in cranial mesenchyme cells may impair their emigration and may be essential for the correct development of the cranial neural folds and neural tube closure (By similarity). Catalyzes ubiquitination and degradation of ZNF622, an assembly factor for the ribosomal 60S subunit, in hematopoietic cells, thereby promoting hematopoietic stem cell renewal . . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . |
Accessions | A0A8I5KU01 ENST00000553700.5 H0YJP0 Q9ULT8 H0YJD4 ENST00000399332.6 ENST00000554882.6 H0YJ72 G3V4V5 ENST00000692835.1 ENST00000691390.1 ENST00000556224.6 Q5XJ19 A0A087X2H1 ENST00000611816.5 A0A8I5QJU2 A0A8I5QJE9 ENST00000688933.1 Q9BRJ0 A0A8I5KUD6 ENST00000693685.1 ENST00000553957.6 ENST00000555915.1 |